Autophagy induction has been observed in hepatoma cells (Hep3B) treated with regorafenib, marked by an increase in both Beclin 1 and LC3-II and a decrease in Bcl-2 levels [161]. The gene discussed is BECN1; the disease is hepatocellular carcinoma.